Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-019025
Filing Date
2025-02-12
Accepted
2025-02-12 17:27:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10956
2 EX-1 c-ex1.htm EX-1 11629
  Complete submission text file 0000950170-25-019025.txt   24601
Mailing Address 388 GREENWICH STREET NEW YORK NY 10013
Business Address 388 GREENWICH STREET NEW YORK NY 10013 2125591000
CITIGROUP INC (Filed by) CIK: 0000831001 (see all company filings)

EIN.: 521568099 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02210
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02210 617-482-2333
PureTech Health plc (Subject) CIK: 0001782999 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92234 | Film No.: 25616194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)